期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

修复基因XRCC4多态性与膀胱癌易感性的Meta分析 被引量：3

Association between polymorphisms in XRCC4 and bladder cancer risk:A Meta-analysis
暂未订购
导出
摘要 目的探讨XRCC4单核苷酸多态性与膀胱癌发病易感性的关联。方法通过检索PubMed、CNKI和万方数据库，检索从1960年1月1日至2015年12月31日国内外已经公开发表的中、英文献，筛选合格文献行Meta分析。结果最终纳入关于XRCC4基因多态性与膀胱癌易感性关联的病例-对照研究10项，计病例组2689例，对照组2915例。Meta分析结果显示，XRCC4基因rs28360317和rs1805377多态性位点与膀胱癌显著相关（rs28360317：BmA：OR=1．339，95％CI：1．088～1．649，P=0．006；BBvs．AA：OR=1．729，95％CI：1．137-2．629，P=0．010；BBvs．BA＋AA：OR=1．638，95％CI：1．144-2．346，P=0．007；rs1805377：BAvs．AA：OR=1．242，95％CI：1．041-1．482，P=0．016；BA＋BBvs．AA：OR=1．216，95％CI：1．023-1．445，P=0．027。以种族为依据的亚组分析揭示，XRCC4基因rs1805377多态性在高加索人群中与膀胱癌发病显著相关：B：OA：OR=1．295，95％CI：1．070-1．566，P=0．008；BAvs．AA：OR=1．362，95％CI：1．101-1．684，P=0．004；BA＋BBvs．AA：OR=1．348，95％CI：1．096-1．659，P-0．005。然而，XRCC4基因rs6869366和rs28360071多态性位点与膀胱癌的易感性无关。结论XRCC4基因rs28360317和rs1805377单核苷酸多态性与膀胱癌发病风险呈显著正相关，可作为膀胱癌患者潜在诊断、筛查分子标志物。 Objective To explore the relevance between XRCC4 polymorphisms and bladder cancer risk in Asian popula- tion. Methods We retrieved PubMed, CNKI and Wanfang databases to search for all eligible studies published from Jan. 1, 1960 to Oct. 31, 2015 （restricted to English and Chinese） to conduct a Meta-analysis. Results A total of 10 case-control studies were enrolled, including 2 689 cases and 2 915 controls. Our work demonstrated that rs28360317 and rs1805377 poly- morphisms in XRCC4 significantly associated with bladder cancer risk： （rs28360317： B vs. A： OR=1. 339, 95%CI： 1,088- 1.649,P=0.006; BB vs. AA：OR=1.729, 95%CI：1.137-2.629,P=0.010; BB vs. BA＋AA：OR=1.638, 95%CI：1.144 -2.346,P=0.007; rs1805377： BAvs. AA：OR： 1.242, 95%CI：1.041-1.482,P=0.016; BA＋BB vs. AA： OR：1.216, 95 % CI ： 1. 023- 1. 445, P=0. 027）. In the stratification analysis by ethnicity, we identified an increased risk of rs1805377 polymorphism and bladder cancer risk in Caucasian population ： （B vs. A： OR =1. 295, 95 % CI ：1. 070- 1. 566, P=0. 008 ; BA vs. AA：OR=1. 362, 95%CI：1.101-1.684, P-=0.004; BA＋BB vs. AA：OR=1.348,95%CI：1.096-1.659,P=O.006）. How ever, no association was identified between rs6869366 and rs28360071 polymorphisms in XRCC4 and bladder cancer risk. Conclusions There is a positive relevance between rs28360317 and rs1805377 polymorphisms and bladder cancer risk, which can serve as a diagnosis and screening molecular biomarker for bladder cancer patients.
作者 张万生 王立国 郭彬彬 于航 韩冬
机构地区 吉林医药学院附属医院泌尿外科
出处 《现代泌尿外科杂志》 CAS 2016年第9期676-680,共5页 Journal of Modern Urology
关键词 膀胱癌 XRCC4 易感性 META分析 bladder cancer XRCC4 risk Meta-analysis
分类号 R737.14 [医药卫生—肿瘤]
  • 相关文献

参考文献14

  • 1ZEEGERS M P, GOLDBOHM R A, VAN DEN BRANDT P A. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)[J]. Cancer Causes & Control : CCC, 2002, 13(1): 83-90.
  • 2DE BOER J G. Polymorphisms in DNA repair and environmental interactions[J]. Mutation Res, 2002, 509(1/2): 201-210.
  • 3ALLEN-BRADY K, CANNON-ALBRIGHT L A, NEUHAUSEN S L, et al. A role for XRCC4 in age at diagnosis and breast cancer risk[Z]. Cancer epidemiology, Biomarkers & prevention:a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, 15(7): 1306-1310.
  • 4LIU Yanhong, ZHOU Keke, ZHANG Haishi, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma[J]. Human Mutation, 2008, 29(3): 381-389.
  • 5CHIU C F, TSAI M H, TSENG H C, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwan Residents patients[J]. Oral Oncol, 2008, 44(9): 898-902.
  • 6MITTAL R D, GANGWAR R, MANDAL R K, et al. Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer[J]. Mol Biol Reports, 2012, 39(2): 1667-1675.
  • 7CHANG C H, CHANG C L, TSAI C W, et al. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan[J]. Anticancer Res, 2009, 29(5): 1777-1782.
  • 8FIGUEROA J D, MALATS N, ROTHMAN N, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk[J]. Carcinogenesis, 2007, 28(8): 1788-1793.
  • 9BROBERG K, BJRK J, PAULSSON K, et al. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer[J]. Carcinogenesis, 2005, 26(7): 1263-1271.
  • 10DERSIMONIAN R, LAIRD N. Meta-analysis in clinical trials[J]. Controlled Clinical Trials, 1986, 7(3): 177-188.

同被引文献17

引证文献3

二级引证文献4

现代泌尿外科杂志
2016年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部